Salivary histatin 5: a new strategy for the treatment of Candida albicans infection
Author:
Affiliation:

Department of Laboratory Medicine, Medical Center Hospital of Qionglai City, Chengdu 611530, China

Clc Number:

R519.3

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    Candida albicans (C. albicans) is an opportunistic pathogen that can cause fungal infection at different sites. At present, drugs for the treatment of C. albicans is single. With the irrational use of clinical drugs, drug resistance of C. albicans is becoming increasingly serious. Histatins 5 (Hst-5) is the most abundant antimicrobial peptide (AMP) secreted from oral saliva. As the first defense line of the host, it has strong antibacterial activity against C. albicans. Its mechanism of action is different from that of traditional antifungal drugs and other antimicrobial peptides, which involves a variety of transport proteins on the surface of C. albicans, MAPK pathway, and various metal ions in vitro. With the in-depth study of Hst-5, it is found that a variety of derivative peptides of Hst-5 (K11R-K17R, P-113Tri, etc.) can play a more vital role in improving antimicrobial efficacy. Therefore, it is particularly important to study the antimicrobial mechanism of Hst-5 and its derived peptides in C. albicans, which will provide a new strategy for the therapy of clinical fungal infections at present.

    Reference
    Related
Get Citation

王泽洪,肖家凤,徐梓倍,等.唾液富组蛋白5——治疗白念珠菌感染的一种新策略[J].中国感染控制杂志英文版,2023,(3):362-368. DOI:10.12138/j. issn.1671-9638.20233688.
Ze-hong WANG, Jia-feng XIAO, Zi-bei XU, et al. Salivary histatin 5: a new strategy for the treatment of Candida albicans infection[J]. Chin J Infect Control, 2023,(3):362-368. DOI:10.12138/j. issn.1671-9638.20233688.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 13,2022
  • Revised:
  • Adopted:
  • Online: April 28,2024
  • Published: